PhiTech
ActiveAI-nativeRNA-Based AI-Powered Clinical Decision Software to Achieve Rare Disease Diagnosis in Weeks, Not Years!
What it does
PhiTech Bioinformatics is a precision medicine company, providing an RNA-based AI-powered clinical diagnostic decision support system for rare diseases
Next to it in Healthcare and bio · AI-powered rare disease diagnosis
- KlinriskPlug and Play PnP 2024
Klinrisk finds progressive kidney disease early before kidney function is lost
- GenehubAntler Antler UK 2022
GeneHub transforms rare disease patient cohorts into research-ready databanks, all controlled by patients!
- Twinn Health500 Global 500G Mena 2
Developer of healthcare tools intended for early disease detection using imaging and AI tools to extend a healthy human lifespan. The company's platform uses MRI scanning and AI to get information about metabolism and body composition, enabling healthcare professionals to look for warning signs of potential inflammation, damage, and disease in major organs, muscles, and bones.
- RowanAI Grant AI Grant Batch 4
AI molecular simulation
- BiorcePlug and Play PnP 2024
Revolutionizing drug development through the power of AI.
- CardiaTec BiosciencesPlug and Play PnP 2024
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
- HeptaPlug and Play PnP 2024
Detect, monitor, and direct effective treatment for liver disease.
- Oxford Cancer AnalyticsPlug and Play PnP 2024
Enabling Curative Cancer Treatment Through Early Detection- Focused on Lung Cancer